by Lorenzo Monasta | Jun 26, 2026 | Italian GBD Initiative, Non-communicable diseases, Uncategorized
On September 3, 2025, Benedetta Armocida, Research Director of the Istituto Superiore di Sanità and member of the Italian GBD Initiative, received the prestigious “2025 GBD Emerging Researcher Award”. Established in 2020, the award celebrates scholars who contribute...
by Lorenzo Monasta | Jun 26, 2026 | Uncategorized
We are happy to announce that, starting this year, the Italian GBD Initiative is collaborating with the website of Epidemiologia & Prevenzione to provide information, insights, and materials to the Italian epidemiological community and stimulate broader...
by Lorenzo Monasta | Oct 1, 2024 | Forecasting, Global Burden of Diseaase Project, Infectious diseases and AMR
By Sara Moraca A new study published in The Lancet predicts that more than 39 million people could die from antibiotic-resistant infections by 2050. This research, conducted by the Global Research on Antimicrobial Resistance (GRAM) Project, represents the first...
by Lorenzo Monasta | Mar 29, 2024 | Infectious diseases and AMR, Italian GBD Initiative
By 2050, it is estimated that antimicrobial resistance (AMR) will cause 10 million annual deaths worldwide, costing up to $100 trillion. Antibiotic resistance (ABR) is the most significant health threat and, in 2019, caused 1.27 million deaths globally. One in 5...
by Lorenzo Monasta | Mar 29, 2024 | Uncategorized
As little is known about the burden of type 1 (T1DM) and type 2 diabetes (T2DM) in adolescents in Western Europe (WE), we aimed to explore their epidemiology among 10-24 year-olds. Estimates were retrieved from the Global Burden of Diseases Study (GBD) 2019. We...
